These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28728424)

  • 41. The utility of immunoassays for urine drug testing.
    Melanson SE
    Clin Lab Med; 2012 Sep; 32(3):429-47. PubMed ID: 22939301
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mechanism of false-negative urine cannabinoid immunoassay screens by Visine eyedrops.
    Pearson SD; Ash KO; Urry FM
    Clin Chem; 1989 Apr; 35(4):636-8. PubMed ID: 2467764
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of drugs of abuse in urine by gas chromatography/mass spectrometry: experience and application.
    Karacić V; Skender L
    Arh Hig Rada Toksikol; 2000 Dec; 51(4):389-400. PubMed ID: 11276966
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A study on photodegradation of methadone, EDDP, and other drugs of abuse in hair exposed to controlled UVB radiation.
    Favretto D; Tucci M; Monaldi A; Ferrara SD; Miolo G
    Drug Test Anal; 2014 Jun; 6 Suppl 1():78-84. PubMed ID: 24817052
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of adulterants on RIA analysis of urine for drugs of abuse.
    Cody JT; Schwarzhoff RH
    J Anal Toxicol; 1989; 13(5):277-84. PubMed ID: 2615338
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cross-reactivity studies and predictive modeling of "Bath Salts" and other amphetamine-type stimulants with amphetamine screening immunoassays.
    Petrie M; Lynch KL; Ekins S; Chang JS; Goetz RJ; Wu AH; Krasowski MD
    Clin Toxicol (Phila); 2013 Feb; 51(2):83-91. PubMed ID: 23387345
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reliability of the cloned-enzyme donor immunoassay (CEDIA) for cocaine in human serum in the range between the detection limit and the cut-off.
    Schütz H; Auch J; Erdmann F; Weiler G; Verhoff MA
    Arzneimittelforschung; 2006; 56(6):414-20. PubMed ID: 16889124
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lower Cutoffs for LC-MS/MS Urine Drug Testing Indicates Better Patient Compliance.
    Krock K; Pesce A; Ritz D; Thomas R; Cua A; Rogers R; Lipnick P; Kilbourn K
    Pain Physician; 2017 Nov; 20(7):E1107-E1113. PubMed ID: 29149155
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Methadone and illegal drugs in hair from children with parents in maintenance treatment or suspected for drug abuse in a German community.
    Pragst F; Broecker S; Hastedt M; Herre S; Andresen-Streichert H; Sachs H; Tsokos M
    Ther Drug Monit; 2013 Dec; 35(6):737-52. PubMed ID: 24263638
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of intect test strips for detecting adulteration of urine specimens used for drugs-of-abuse testing.
    King EJ
    J Anal Toxicol; 2000 Sep; 24(6):456. PubMed ID: 10999355
    [No Abstract]   [Full Text] [Related]  

  • 51. Response of CEDIA amphetamines assay after a single dose of bitter orange.
    Nguyen DT; Bui LT; Ambrose PJ
    Ther Drug Monit; 2006 Apr; 28(2):252-4. PubMed ID: 16628139
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detectability of designer benzodiazepines in CEDIA, EMIT II Plus, HEIA, and KIMS II immunochemical screening assays.
    Pettersson Bergstrand M; Helander A; Hansson T; Beck O
    Drug Test Anal; 2017 Apr; 9(4):640-645. PubMed ID: 27366870
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Toxicological screening for drugs of abuse in samples adulterated with household chemicals.
    Uebel RA; Wium CA
    S Afr Med J; 2002 Jul; 92(7):547-9. PubMed ID: 12197198
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vivo adulteration: excess fluid ingestion causes false-negative marijuana and cocaine urine test results.
    Cone EJ; Lange R; Darwin WD
    J Anal Toxicol; 1998 Oct; 22(6):460-73. PubMed ID: 9788521
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [On-site testing for drug abuse in urine].
    Espnes KA; Spigset O; Delaveris GJ; Mørland J; Smith-Kielland A
    Tidsskr Nor Laegeforen; 2006 Sep; 126(17):2257-60. PubMed ID: 16967064
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Elevated urine zinc concentration reduces the detection of methamphetamine, cocaine, THC and opiates in urine by EMIT.
    Lin CN; Strathmann FG
    J Anal Toxicol; 2013; 37(9):665-9. PubMed ID: 23843421
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adulterants causing false negatives in illicit drug testing.
    Mikkelsen SL; Ash KO
    Clin Chem; 1988 Nov; 34(11):2333-6. PubMed ID: 3052928
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of the integrated E-Z split key(®) cup II for rapid detection of twelve drug classes in urine.
    Greene DN; Lehman CM; McMillin GA
    J Anal Toxicol; 2011 Jan; 35(1):46-53. PubMed ID: 21219703
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Performance evaluation of three on-site adulterant detection devices for urine specimens.
    Peace MR; Tarnai LD
    J Anal Toxicol; 2002 Oct; 26(7):464-70. PubMed ID: 12423001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.